About NEJM - The New England Journal of Medicine
The New England Journal of Medicine (NEJM) is recognized as the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, …
NEJM Author Center - The New England Journal of Medicine
The New England Journal of Medicine (NEJM) continues to lead in the publication of influential, highly cited clinical research.
New Manuscripts | NEJM Author Center
Welcome and thank you for considering the New England Journal of Medicine (NEJM) as a venue for your work. As the oldest continuously-published medical journal, our mission since 1812 …
Images in Clinical Medicine - The New England Journal of Medicine
Explore Images in Clinical Medicine articles from The New England Journal of Medicine
Issue Index | New England Journal of Medicine
Index of all Issues from New England Journal of Medicine
Weekly CME Program | NEJM
NEJM Weekly CME The Massachusetts Medical Society designates each journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™.
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Mar 5, 2025 · Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis–associated organisms between …
Review Article - The New England Journal of Medicine
Nov 20, 2025 · This review updates the pathophysiology and disease course of acromegaly, focusing on the general clinician’s key role in early diagnosis and management.
Medical Management and Revascularization for Asymptomatic …
Nov 21, 2025 · Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. …
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated ...
Apr 30, 2025 · Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase …